StepStone Group LP holds a concentrated book of 18 stocks worth $207.5M as of Q1 2026 (disclosed May 15, 2026, a ~45-day 13F lag). This quarter they opened Xanadu Quantum Technolo-CL B and trimmed Kodiak AI Inc.. Their largest long position is Karman Holdings Inc at 34% of the equity book.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1502287/holdings"
Use Arkolith to show StepStone Group LP's latest holdings, largest changes, and filing provenance.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
95% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Karman Hldgs Inc COMMON STOCK | $70.2M | 877.3K | 33.8% | —Held | |
| 2 | Stubhub Hldgs Inc CL A | $47.2M | 7.56M | 22.7% | —Held | |
| 3 | Xanadu Quantum Technolo Ltd SUB VTG B | $26.2M | 3.42M | 12.6% | ▲New New position | |
| 4 | Onkure Therapeutics Inc COM CL A | $11.0M | 2.66M | 5.3% | ▲+441% Added · +2.2M sh | |
| 5 | Uipath, Inc. CL A | $10.0M | 903.0K | 4.8% | —Held | |
| 6 | Kodiak AI Inc. COM | $9.8M | 1.41M | 4.7% | ▼~0% Reduced · −226 sh | |
| 7 | Entrada Therapeutics Inc. COM | $9.6M | 761.3K | 4.6% | —Held | |
| 8 | Navan Inc CL A | $6.4M | 483.9K | 3.1% | ▲+13% Added · +57K sh | |
| 9 | Phathom Pharmaceuticals Inc. COM | $4.7M | 422.1K | 2.3% | —Held | |
| 10 | Eikon Therapeutics Inc COM | $4.2M | 395.3K | 2.0% | ▲New New position | |
| 11 | Draftkings Inc New COM CL A | $3.5M | 160.9K | 1.7% | —Held | |
| 12 | Chime Finl Inc COM SHS CL A | $2.8M | 150.0K | 1.4% | —Held | |
| 13 | Mongodb Inc. CL A | $497K | 2.0K | 0.2% | ▲New New position | |
| 14 | Grove Collaborative Hold Inc COM CL A | $487K | 380.7K | 0.2% | —Held | |
| 15 | Tenaya Therapeutics Inc COM | $319K | 462.2K | 0.2% | —Held | |
| 16 | Gen Digital Inc RIGHT 99/99/9999 | $249K | 622.9K | 0.1% | —Held | |
| 17 | Via Transn Inc COM CL A | $240K | 16.0K | 0.1% | —Held | |
| 18 | Servicenow Inc COM | $67K | 638 | 0.0% | ▼−96% Reduced · −15K sh |
As-of date vs the date the SEC received each filing
Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.